STABILITY, SCALABILITY, SIMPLICITY
Unlocking the Full Potential of Cyclic Peptides
Our chemistry enhances peptide stability and expands what’s screenable, accelerating the path to better, more durable drug candidates.
Modern discovery platforms are producing incredible peptide hits, but poor cyclisation chemistries limit their applicability.
That’s where we come in.
Our proprietary two-step chemical reaction transforms linear peptides into stable, nature-mimicking macrocycles and keeps them that way.
Built for Discovery Platforms
Perfectly suited for mRNA display, phage display, and DEL screens. Expand your library. Improve your hits.
Post-Cyclisation Flexibility
Add functionality after cyclisation without disrupting the structure, opening doors for innovation.
Late-Stage Applicability
Can be introduced at a late stage of your synthesis workflow, allowing integration without disrupting upstream processes.
Stays Cyclic
Unlike traditional methods, our chemistry locks peptides in their cyclic form, no reversion, no instability.
Cost-Effective & Scalable
Our chemistry uses low-cost, widely available reagents, making it an affordable solution.
Let’s collaborate to accelerate stable, scalable solutions in peptide drug discovery.
Complete Our Survey
Share your insights so we can tailor our technology to better support your goals.
Pre-Print
Read our current pre-print published paper in ChemRxiv – Next Generation Cyclic Peptidomimetics.
More Stable Peptides = Better Potential Therapeutics
Whether you’re developing next-generation therapeutics or optimising diagnostic peptides, our chemistry gives your team the edge. No more trial-and-error with fragile macrocycles. Better potential therapeutics, faster.
Ready to Level Up Your Screening?
Let’s talk about how our platform can integrate into your current discovery workflow and supercharge your results.
A University of Glasgow project
Supported by Innovate UK ICURe Discover Programme.
